Streamline Health Earnings Estimate

STRM Stock  USD 4.60  0.09  2.00%   
The next projected EPS of Streamline Health is estimated to be 0.0 with future projections ranging from a low of 0.0 to a high of 0.0. Streamline Health's most recent 12-month trailing earnings per share (EPS TTM) is at -2.35. Please be aware that the consensus of earnings estimates for Streamline Health Solutions is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Streamline Health is projected to generate 0.0 in earnings per share on the 31st of January 2025. Streamline Health earnings estimates show analyst consensus about projected Streamline Health Solutions EPS (Earning Per Share). It derives the highest and the lowest estimates based on Streamline Health's historical volatility. Many public companies, such as Streamline Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Streamline Health Revenue Breakdown by Earning Segment

By analyzing Streamline Health's earnings estimates, investors can diagnose different trends across Streamline Health's analyst sentiment over time as well as compare current estimates against different timeframes. As of the 1st of February 2025, Gross Profit is likely to drop to about 9.9 M. In addition to that, Pretax Profit Margin is likely to grow to -0.91
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Streamline Health Earnings Estimation Breakdown

The calculation of Streamline Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Streamline Health is estimated to be 0.0 with the future projection ranging from a low of 0.0 to a high of 0.0. Please be aware that this consensus of annual earnings estimates for Streamline Health Solutions is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-0.61
0.00
Lowest
Expected EPS
0.0
0.00
Highest

Streamline Health Earnings Projection Consensus

Suppose the current estimates of Streamline Health's value are higher than the current market price of the Streamline Health stock. In this case, investors may conclude that Streamline Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Streamline Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of January 2025Current EPS (TTM)
151.86%
-0.61
0.0
-2.35

Streamline Health Earnings History

Earnings estimate consensus by Streamline Health analysts from Wall Street is used by the market to judge Streamline Health's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Streamline Health's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Streamline Health Quarterly Gross Profit

4.42 Billion

As of the 1st of February 2025, Retained Earnings is likely to grow to about (98.9 M). In addition to that, Retained Earnings Total Equity is likely to drop to about (91.7 M) As of the 1st of February 2025, Common Stock Shares Outstanding is likely to drop to about 4.1 M. In addition to that, Net Loss is likely to grow to about (9.7 M).
Hype
Prediction
LowEstimatedHigh
0.214.1912.55
Details
Intrinsic
Valuation
LowRealHigh
0.338.6917.05
Details
Naive
Forecast
LowNextHigh
0.094.6312.98
Details
1 Analysts
Consensus
LowTargetHigh
20.4822.5024.98
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Streamline assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Streamline Health. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Streamline Health's stock price in the short term.

Streamline Health Earnings per Share Projection vs Actual

Actual Earning per Share of Streamline Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Streamline Health Solutions predict the company's earnings will be in the future. The higher the earnings per share of Streamline Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Streamline Health Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Streamline Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Streamline Health should always be considered in relation to other companies to make a more educated investment decision.

Streamline Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Streamline Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-12-12
2024-10-31-0.03-0.61-0.581933 
2024-09-11
2024-07-31-0.04-0.05-0.0125 
2024-06-11
2024-04-30-0.04-0.05-0.0125 
2024-04-30
2024-01-31-0.04-0.020.0250 
2023-12-13
2023-10-31-0.04-0.020.0250 
2023-09-13
2023-07-31-0.05-0.040.0120 
2023-06-12
2023-04-30-0.05-0.050.0
2023-04-26
2023-01-31-0.05-0.040.0120 
2022-12-14
2022-10-31-0.06-0.07-0.0116 
2022-09-07
2022-07-31-0.07-0.070.0
2022-06-08
2022-04-30-0.05-0.06-0.0120 
2022-04-27
2022-01-31-0.06-0.0250.03558 
2021-12-08
2021-10-31-0.05-0.1-0.05100 
2021-09-08
2021-07-31-0.05-0.00150.048597 
2021-06-08
2021-04-30-0.05-0.07-0.0240 
2021-04-21
2021-01-31-0.06-0.050.0116 
2020-12-08
2020-10-31-0.07-0.040.0342 
2020-09-09
2020-07-31-0.05-0.040.0120 
2020-06-10
2020-04-30-0.06-0.030.0350 
2020-04-22
2020-01-31-0.05-0.040.0120 
2020-01-07
2019-10-310.01-0.01-0.02200 
2019-09-11
2019-07-310.01-0.02-0.03300 
2019-06-12
2019-04-300.020.01-0.0150 
2019-04-22
2019-01-31-0.010.010.02200 
2018-12-10
2018-10-31-0.04-0.010.0375 
2018-09-11
2018-07-31-0.02-0.04-0.02100 
2018-06-06
2018-04-30-0.04-0.030.0125 
2018-04-25
2018-01-31-0.060.00160.0616102 
2017-12-12
2017-10-31-0.062.0E-40.0602100 
2017-09-13
2017-07-31-0.07-0.060.0114 
2017-06-12
2017-04-30-0.1-0.10.0
2017-04-10
2017-01-31-0.1-0.060.0440 
2016-12-07
2016-10-31-0.08-0.1-0.0225 
2016-09-07
2016-07-31-0.09-0.060.0333 
2016-06-08
2016-04-30-0.1-0.10.0
2016-04-20
2016-01-31-0.09-0.090.0
2015-12-10
2015-10-31-0.11-0.040.0763 
2015-09-03
2015-07-31-0.12-0.050.0758 
2015-06-09
2015-04-30-0.12-0.120.0
2015-04-16
2015-01-31-0.15-0.17-0.0213 
2014-12-09
2014-10-31-0.13-0.130.0
2014-09-09
2014-07-31-0.11-0.14-0.0327 
2014-07-24
2014-04-30-0.06-0.16-0.1166 
2013-12-12
2013-10-31-0.16-0.5-0.34212 
2013-06-05
2013-04-30-0.06-0.15-0.09150 
2013-04-24
2013-01-31-0.46-0.090.3780 
2012-09-12
2012-07-31-0.03-0.04-0.0133 
2012-06-07
2012-04-300.020.050.03150 
2010-09-08
2010-07-31-0.08-0.010.0787 
2010-06-03
2010-04-30-0.03-0.13-0.1333 
2010-04-07
2010-01-310.160.170.01
2009-12-09
2009-10-310.02-0.03-0.05250 
2009-09-09
2009-07-310.05-0.0019-0.0519103 
2009-06-09
2009-04-30-0.020.00170.0217108 
2007-08-27
2007-07-310.08-0.12-0.2250 
2007-05-21
2007-04-300.06-0.05-0.11183 
2007-04-02
2007-01-310.240.03-0.2187 
2006-08-21
2006-07-310.030.02-0.0133 
2006-03-29
2006-01-310.110.290.18163 
1997-08-27
1997-07-31-0.18-0.4-0.22122 
1997-05-27
1997-04-30-0.18-0.32-0.1477 
1997-03-26
1997-01-31-0.1-0.29-0.19190 
1996-11-18
1996-10-310-0.13-0.13
1996-08-22
1996-07-31-0.04-0.020.0250 

About Streamline Health Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Streamline Health earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Streamline Health estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Streamline Health fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-104.1 M-98.9 M
Retained Earnings Total Equity-87.3 M-91.7 M
Earnings Yield(0.98)(0.93)
Price Earnings Ratio(1.06)(1.01)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
12.131
Earnings Share
(2.35)
Revenue Per Share
5.249
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.11)
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.